Podofilox
Antivirals
Sold as Condylox
- Drug class
- Antivirals
- Availability
- Prescription only
- Routes
- Topical
- Markets covered
- 1
- Products on record
- 1
- FDA reports (12 mo)
- 1
Overview
Plain-language summary, compiled from the cited regulatory records
Podofilox is an antiviral medication belonging to the Antivirals (D06BB) drug class [1]. It is approved for the topical treatment of external genital warts and perianal warts [1]. While anogenital warts typically have a distinct appearance, it is recommended to obtain histopathologic confirmation if there is any uncertainty regarding the diagnosis [1]. This is particularly important to distinguish warts from conditions such as squamous cell carcinoma and "Bowenoid papulosis" [1].
In the market, podofilox is available under various brand names, including Condylox [1]. Over the past 12 months, there has been 1 adverse event report associated with this active ingredient [2]. The most frequently reported adverse events include hunger, product size issues, and product use complaints [2].
This is not medical advice. Consult a qualified healthcare professional.
Regulatory status by market
| Market | Regulator | Products | Last revision |
|---|---|---|---|
| US United States | FDA | 1 | January 29, 2024 |
USUnited States· FDA
1 product
Uses
INDICATIONS AND USAGE
5% is indicated for the topical treatment of anogenital warts (external genital warts and perianal warts). This product is not indicated in the treatment of mucous membrane warts (see PRECAUTIONS ). Diagnosis Although anogenital warts have a characteristic appearance, histopathologic confirmation should be obtained if there is any doubt of the diagnosis.
Differentiating warts from squamous cell carcinoma and "Bowenoid papulosis" is of particular concern. 5%.
How to take
Sources & citations
- [1]FDA DailyMed · 032e4bcb-b1ed-40… · revised January 29, 2024 [PDF]
- [2]OpenFDA adverse-event reports (US), 12 months ending June 4, 2026.
Information on this page is compiled from public regulatory records. Drugvu is not affiliated with any regulator or pharmaceutical manufacturer. This is not medical advice. Always consult a qualified healthcare professional.